Revolution Medicines (RVMD) Other Working Capital Changes (2019 - 2026)

Revolution Medicines' Other Working Capital Changes history runs 8 years deep, the most recent figure standing at -$2.1 million for Q1 2026.

• On a quarterly basis, Other Working Capital Changes fell 38.11% year-over-year to -$2.1 million in Q1 2026; TTM through Mar 2026 was -$1.5 million, a 16.49% increase from a year earlier, with the FY2025 full-year figure at -$957000.0, down 290.61% from the prior year.
• Other Working Capital Changes grew to -$2.1 million in Q1 2026 per RVMD's latest filing, from -$2.8 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $10.5 million in Q1 2026 and bottomed at -$6.4 million in Q1 2025.
• The 5-year median for Other Working Capital Changes is $2.3 million (2023), against an average of $2.1 million.
• Biggest YoY gain for Other Working Capital Changes was 1277.02% in 2025; the steepest drop was 1865.88% in 2025.
• Year by year, Other Working Capital Changes stood at -$2.4 million in 2022, then plunged by 143.02% to -$5.9 million in 2023, then surged by 79.07% to -$1.2 million in 2024, then plunged by 125.63% to -$2.8 million in 2025, then grew by 25.0% to -$2.1 million in 2026.
• Per Business Quant, the three latest RVMD Other Working Capital Changes figures stand at -$2.1 million (Q1 2026), -$2.8 million (Q4 2025), and -$4.0 million (Q3 2025).